Navigation Links
Intellectual Property Lawyer Available for Comment on Recent Supreme Court Ruling

BUFFALO, N.Y., March 23, 2012  /PRNewswire/ -- Jeremy P. Oczek, a registered patent attorney and Member in the Intellectual Property and Technology Group of Bond Schoeneck & King, is available to comment on the recent Supreme Court ruling that has significant implications for the medical and biotechnology industries.

In Mayo Collaborative Services v. Prometheus Labs, Inc., the Court unanimously ruled that a medicine dosing process that merely describes a "natural law" is not eligible for patent protection. Writing for the Court, Justice Stephen G. Breyer said Prometheus Laboratories' medical tests, designed to help doctors determine the most beneficial drug dosage by describing the correlation between metabolites in patients' blood and the likelihood that the dosage will be ineffective or harmful, were directed to laws of nature and therefore not eligible for patent protection. Justice Breyer cited Einstein's E=mc(2) formula and Newton's law of gravity as celebrated examples of natural laws that courts have long held are not patentable.

Mr. Oczek, a registered patent attorney in the Buffalo office of Bond, Schoeneck & King, PLLC, has litigated patent cases in federal courts throughout the United States. He has offered commentary on intellectual property issues for many national publications, including The National Law Journal, BNA's Patent, Trademark & Copyright Journal and Law360, and has published articles on intellectual property law in the Buffalo Law Journal, Sedona Conference Journal and Boston College Law Review.

Bond, Schoeneck & King, PLLC is a full-service law firm of more than 200 attorneys with offices in New York State, Kansas and Florida. For a complete list of practice areas and industries served, please visit

To arrange a phone interview with Mr. Oczek, please contact Kim Parr, Director of Public Relations at Latorra, Paul & McCann at (315) 476-1646, ext. 225 or email


Opinion by Justice Stephen G. Breyer:

New York Times: Justices Back Mayo Clinic Argument on Patents:

Wall Street Journal: Top Court's Patent Rejection Alarms the Biotech Industry:

Jeremy P. Oczek:

Bond, Schoeneck & King:

Kim Parr
Latorra, Paul & McCann
(315) 476-1646, ext. 225

SOURCE Bond Schoeneck & King
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. PharmacoFore, Inc. Announces Appointment of Chief Medical Officer and Vice President of Intellectual Property
2. Ontario Institute for Cancer Research Announces Enhancements to its Intellectual Property Development and Commercialization Program
3. iPierian Expands Leadership Team With Experienced Business Development and Intellectual Property Executives
4. China YCT International Group, Inc. Announces That the State Intellectual Property Office of the Peoples Republic of China has Approved a Patent to its Operating Subsidiary, Shandong Spring Pharmaceutical Co. Ltd.
5. BIO Ventures for Global Health Chosen to Administer the GSK and Alnylam Intellectual Property Pool
6. Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property
7. Finn, Warnke & Gayton Announces A New Service For Biotechnology Firms - A Platform To Sell Intellectual Property
8. Veteran Intellectual Property Team Joins Brown Rudnick
9. EPIX Pharmaceuticals, Inc. Announces the PRX-00023 Therapeutics CNS Program in Phase 2b/3 Will Be Part of the Intellectual Property Offered for Sale at the September 30, 2009 Auction
10. Epix Pharmaceuticals, Inc. Announces the PRX-08066 Therapeutics Program in Phase 2 for Respiratory Indication Will Be Part of The Intellectual Property Offered for Sale at the September 30, 2009 Auction
11. Hill-Rom Announces Sale of Negative Pressure Wound Therapy Intellectual Property
Post Your Comments:
(Date:6/27/2016)... Hill, N.C. (PRWEB) , ... June 27, 2016 ... ... U.S. commercial operations for Amgen, will join the faculty of the University ... serve as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a ...
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
Breaking Biology Technology:
(Date:5/20/2016)... MINNEAPOLIS , May 20, 2016  VoiceIt ... technology partnership with VoicePass. By working ... user experience.  Because VoiceIt and VoicePass take slightly ... two engines increases both security and usability. ... expressed excitement about this new partnership. ...
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: ) , ... services, but it also plays a fundamental part in enabling ...
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
Breaking Biology News(10 mins):